A protein inhibited by GSK’s Rukobia could be culprit behind HIV comorbidities, study suggests

Antiretroviral therapy, or ART, has made it possible for HIV-positive people to live just as long as those without the virus. But though their lifespans may be equal, healthspans are another matter: People with HIV start experiencing chronic health problems, like liver and heart disease, an average of 16 years earlier than their HIV-negative peers.

error: Content is protected !!